Periodic Reporting for period 1 - IMMUNOMARK (Omics integration for precision cancer immunotherapy)

Checkpoint inhibitor therapy constitutes a promising cancer treatment strategy that targets the immune checkpoints to re-activate silenced T cell cytotoxicity. Immune checkpoint blockade (ICB) demonstrated durable responses and acceptable toxicity. However, up to ~85% of...